Cristina
Tejera Pérez
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublications in collaboration with researchers from AstraZeneca (United Kingdom) (1)
2022
-
Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy
Diabetes Therapy, Vol. 13, Núm. 7, pp. 1281-1298